Louisiana Medicaid : The state provides limited coverage for orlistat, a non-GLP-1 weight-loss drug, but does not cover GLP-1s specifically for obesity treatment
It is therefore important for GPs to have a thorough understanding of the more common pigmented lesions in childhood and adolescence, and to be able to recognise suspicious features that should prompt further action
For IM, stretch it taut
Stay tuned, lots of retatrutide, orforglipron, cagrisema and multiple other trial results coming in May and June
Headache 60(4):655664 Won L, Kraig RP (2020) Insulin-like growth factor-1 inhibits spreading depression-induced trigeminal calcitonin gene related peptide, oxidative stress & neuronal activation in rat
Individuals who may need to avoid or use retatrutide with caution include: Those with severe gastroparesis or other severe gastrointestinal conditions that could be worsened by delayed gastric emptying this is a recognised caution for the class in UK SmPCs People with a history of pancreatitis , given the unconfirmed but precautionary signal associated with GLP-1-based therapies Those with a history of gallbladder disease or gallstones , given the class-associated risk of cholelithiasis and cholecystitis Those who are pregnant or breastfeeding , as safety data in these populations is entirely absent